Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Vancouver risk calculator found to improve lung cancer screening

The Vancouver risk calculator (VRC) offers superior guidance for predicting the risk of malignancy in patients receiving CT lung cancer screening compared to the American College of Radiology Lung Imaging Reporting and Data System (Lung-RADS), according to a new study.

Thumbnail

Total-body PET/CT scanner gains FDA clearance

Shanghai, China-based United Imaging Healthcare announced Tuesday, Jan. 22, that its uEXPLORER total-body scanner has received FDA clearance.

Thumbnail

Community hospital in Massachusetts adds interventional radiology program

South Shore Hospital in Weymouth, Massachusetts, has opened a new interventional radiology program, according to a new report from Weymouth News.

Thumbnail

More groups ask CMS to push back ACO deadline

More industry groups are pushing back against an upcoming deadline for accountable care organizations (ACOs) to apply to the updated Medicare Shared Savings Program.

Thumbnail

AI in healthcare alliance launches, announces officers

The Alliance for Artificial Intelligence in Healthcare (AAIH) has officially launched after the board of directors held the organization’s inaugural meeting Jan. 9 in San Francisco.

Thumbnail

Medicare reimbursements don’t cover the cost of care

Medicare payments in 2019 aren’t likely to cover the cost of delivering care for two-thirds of medical practices, according to a survey from the Medical Group Management Association (MGMA).

FDA takes new steps to modernize 510(k) clearance pathway for medical devices

"In taking these new steps today, we’re reaffirming our commitment to continually strengthening our review process, so that it can continue to serve and protect American patients well for years to come,” wrote FDA Commissioner Scott Gottlieb, MD, and Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health (CDRH), in a recent statement.

Thumbnail

As insulin prices rise, managing diabetes becomes more expensive

The average annual cost of managing type 1 diabetes has skyrocketed, with the rising cost of insulin being a main contributor, according to a new issue brief from the Health Care Cost Institute.